Journal article
Cardiorenal Outcomes Among Patients With Atrial Fibrillation Treated With Oral Anticoagulants
Abstract
RATIONALE & OBJECTIVE: Direct oral anticoagulants (DOACs) have progressively replaced vitamin K antagonists (VKAs) for stroke prevention in patients with nonvalvular atrial fibrillation (AF). DOACs cause fewer bleeding complications, but their other advantages, particularly related to kidney outcomes, remain inconclusive. We studied the risks of chronic kidney disease (CKD) progression and acute kidney injury (AKI) after DOAC and VKA …
Authors
Trevisan M; Hjemdahl P; Clase CM; de Jong Y; Evans M; Bellocco R; Fu EL; Carrero JJ
Journal
American Journal of Kidney Diseases, Vol. 81, No. 3, pp. 307–317.e1
Publisher
Elsevier
Publication Date
March 2023
DOI
10.1053/j.ajkd.2022.07.017
ISSN
0272-6386